Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Imunon, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 18 | 22 | +4 |
| Shares | 412.5K | 419.9K | +7.45K (+1.8%) |
| Value | $402.9K | $285.9K | −$117.0K (−29.0%) |
New holders (5)
Institutions that held Imunon, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 28,569 | $19.0K | 0.00% |
| Virtu Financial LLC | 25,860 | $18.0K | 0.00% |
| Two Sigma Securities, LLC | 13,841 | $9.41K | 0.00% |
| Bank of America Corp | 137 | $93 | 0.00% |
| Game Plan Financial Advisors, LLC | 2 | $1 | 0.00% |
Sold out (1)
Institutions that held Imunon, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| JPMorgan Chase & Co | 11 | $11 |